- Consumer Products
- Latest 29.74
- Currency US$
- Percent Change
- Volume 438,034
- Tue May 21, 2013 4:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||May 6||$-0.21||Aug 7||$-0.18|
12 months ended May 21, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes.